2017 - PhD Chemistry, City University of New York
2016 - MPh Chemistry, City University of New York
2005 - BA Psychology, Columbia University
Dr Lipkin, a Texas native, has many years of professional scientific editing experience for multiple international companies. He has worked as a scientific data analyst and biostatistician, brain imaging technician, radiological imaging technician, structural biology laboratory technician, radiochemist, and computational chemist/ biophysicist. He completed a postdoctoral fellowship in artificial intelligence (AI)/data science and currently works in that field. As a PhD candidate, his computational chemistry research on the Ebola virus fusion peptide received a prestigious United States National Science Foundation RAPID grant. He has published peer-reviewed research articles on topics such as Golgi staining of human brain tissue, PET/MRI imaging in Lyme disease, molecular dynamics simulations, and a review on simulations of antimicrobial peptides. Dr Lipkin has also edited many manuscripts in the subject areas of occupational and public health.
Dr Lipkin has published seven peer-reviewed papers (five as first author) in the journals Archives of General Psychiatry, Journal of Neuroscience Methods, Biophysical Journal, Journal of Membrane Biology, Journal of Peptide Science, Philosophical Transactions of the Royal Society B, and Journal of Physical Chemistry B. He has presented at scientific conferences including the Annual Meeting of the Biophysical Society.
Dr Lipkin has worked as a scientific editor since 2011. He previously worked for several international companies. He joined Edanz Group as an editor in 2016.